A devastating loss for the #breastcancer community 💔 But swaggsheila fierce advocacy, kind soul, contagious smile & awesome hugs inspired us all to do better, be better & work together to provoke change.
Holding #BCSM friends & family close. May her memory be a blessing 🙏🏼

Are you a cancer patient advocate? Research advocate? Policy advocate? Community advocate? Are you a person with a diagnosis or history of cancer interested in advocacy but not sure where to start? We need your voice and would love to have you join us!
advocatecollaborative.org/join-us/

Good friend & SCLC expert Misty Dawn Shields reviews salvage therapies for our patients with ES-SCLC

#TexasLung24 TLC Conference

As an interested party in #AirPollution since my first publication 30 years ago, I genuinely believe that the work from Charles Swanton Cancer Research UK in #lungcancer in #neversmokers BTOG #BTOG24 will contribute to global health & environmental policy in multiple ways

As #ASCO24 ASCO approaches, we wanted to invite our colleagues to a healthy🏃‍♂️alternative in Chicago 🏙️

The #OncoAlertASCO5k 🚨is back and OncoAlert would like to invite anyone who would like to participate to do so.

Where and When:
Saturday June 1st, 2024 at 7AM (local

The OncoAlert🚨NEWSLETTER OUT‼️
Covering April 12-18, 2024

REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

COVERING
✅NEW Prostate #cancer guidelines European Association of Urology (EAU)
✅The Lancet #BreastCancer Commission
✅1st line Pembro & cemiplimab in🫁 #NSCLC 🧪
✅RADICALS RT ☢️in

Interesting study! Whether treatment is a segmentectomy, lobectomy, or even SBRT, we need to better understand recurrence in Stage Ia #NSCLC (up to 20% risk) to appropriate treatment & surveillance.
Will AI be the answer?
pubs.rsna.org/doi/10.1148/ra…
#LCSM

A must-attend educational session at ASCO24 - Jill Feldman
Ramy Sedhom, MD
oncodaily.com/49011.html

#ASCO24 #Cancer #EGFR #SupportiveCare #Healthcare #LungCancer #OncoDaily #Oncology

Words couldn't be more true - In the era of personalized care, the tumor is not the target! TY Ramy Sedhom, MD
A must-attend ed session #ASCO24 :
Fostering Equitable Supportive Care for Black Patients, Older Adults, & Patients with Prognostic Uncertainty
bit.ly/49upCfe
#LCSM

Fabulous AdvocateCollaborative (ACE) meeting following SWOG Cancer Research Network & AACR, sharing working group interests, BoD updates, ASCO plans, and intentions for 2024 and beyond. #PatientAdvocacy #ResearchAdvocacy #PolicyAdvocacy #GSD

The OncoAlert 🚨Newsletter is Out
Covering April 5th-12th, 2024

REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

Discussing:
✅ U.S. FDA approval trastuzumab dx🇺🇸
✅Durvalumab in Small Cell #LungCancer 🫁
✅ALINA 🫁 #NSCLC out on NEJM
✅CD70 CART in

Hey #MedOnc , I need help w/a question & any resources appreciated:
Is there an updated historical survival rate for #EGFR #NSCLC over the past 5 yrs, 10 yrs, 15 yrs years? Or pre & post Osi?
Any data on OS w/different Rx sequencing post Osi?
Thank you!
#lungcancer #LCSM

As advocates, we absolutely concur that we need to work together to 'Make Cancer Less Shitty' (literally and figuratively) through right-sized dosing, personalized therapies, and access to quality supportive care! #SuppOnc #SurvOnc #AACR24 #QoL
Thanks Make Cancer Less Shitty

.Christine Lovly, MD, PhD raises lots of important questions here. I was asking one of my IASLC Academy mentees just yesterday how often patients get tested for co-mutations (STK11/LKB1, TP53) that may inform Tx response. The answer: we still have a long way to go. #AACR24 #LCSM

.Anna D. Barker, Ph.D opens the #AACRSSP with reminding the advocates that Scientists and Survivors need to work together to “ Build Bridges for Progress Against Cancer” #aacr24 #aacrssp #mmsm

A warm invitation to Biomarker Positive Disease:
A personalised approached to selecting Targeted Tx in #LungCancer 🫁& Beyond by our collaborators at Springer IME

Link: …ung-cancer.ime.springerhealthcare.com/?utm_source=on…

with Experts:Lizza Hendriks 🇳🇱Solange Peters 🇨🇭Jaime L. Schneider, M.D., Ph.D. 🇺🇸
Submit your

Oooooh! This launched 2 weeks ago and looks like EVERYTHING advocates have been asking for in the way of personalized and evolving therapies to address metastatic cancers! #AACR24 #AACR2024 OncoAlert

Starting soon! #AACR24
(And nailed it with the title)
#bcsm #crcsm #gyncsm #lcsm #mmsm

The OncoAlert 🚨Newsletter is Out‼️
Covering March 29- April 4th, 2024

REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale…

Discussing:
✅Hallmarks of Systemic Disease ( Charles Swanton & Hananan)
✅Global Cancer Statistics🌐 by American Cancer Society
✅Contact01🫁 in

Excited to share that four of our medical students Hebrew University have been awarded scholarships from the Israeli Lung Cancer Foundation for their research Hadassah on lung cancer ! Future is bright🎓🔬. Big thanks to Shani Shilo and ILCF for their support #Research #LungCancer